171 related articles for article (PubMed ID: 1541265)
21. Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.
Proud D; Pierce JV; Pisano JJ
J Lab Clin Med; 1980 Apr; 95(4):563-74. PubMed ID: 6153694
[TBL] [Abstract][Full Text] [Related]
22. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
Sugi T; Mclntyre JA
Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of kininogen gene expression by estrogen and progesterone in vivo.
Chen LM; Chung P; Chao S; Chao L; Chao J
Biochim Biophys Acta; 1992 Jun; 1131(2):145-51. PubMed ID: 1610894
[TBL] [Abstract][Full Text] [Related]
24. Direct radioimmunoassay for rat T-kininogen.
Jacob B; Thierry D; Françoise S; Alhenc-Gelas F; Francis G; Frédéric E
Biochem Biophys Res Commun; 1987 Apr; 144(2):1090-7. PubMed ID: 3579929
[TBL] [Abstract][Full Text] [Related]
25. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.
Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W
J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705
[TBL] [Abstract][Full Text] [Related]
26. Identification of T-kininogen in rat urine.
Okamoto H; Itoh N; Uwani M
Biochem Pharmacol; 1987 Sep; 36(18):2979-84. PubMed ID: 3651176
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of two kinds of low molecular weight kininogens from rat (non-inflamed) plasma. One resistant and the second sensitive to rat glandular kallikreins.
Enjyoji K; Kato H; Hayashi I; Oh-ishi S; Iwanaga S
J Biol Chem; 1988 Jan; 263(2):965-72. PubMed ID: 3335530
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
Sugi T; McIntyre JA
Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
[TBL] [Abstract][Full Text] [Related]
29. Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen.
Olafsson I; Löfberg H; Abrahamson M; Grubb A
Scand J Clin Lab Invest; 1988 Oct; 48(6):573-82. PubMed ID: 3064278
[TBL] [Abstract][Full Text] [Related]
30. Limited proteolysis of T-kininogen (thiostatin). Release of comparable fragments by different endopeptidases.
Moreau T; Gutman N; Faucher D; Gauthier F
J Biol Chem; 1989 Mar; 264(8):4298-303. PubMed ID: 2647733
[TBL] [Abstract][Full Text] [Related]
31. Limited proteolysis of human low-molecular-mass kininogen by tissue kallikrein. Isolation and characterization of the heavy and the light chains.
Müller-Esterl W; Rauth G; Lottspeich F; Kellermann J; Henschen A
Eur J Biochem; 1985 May; 149(1):15-22. PubMed ID: 2581778
[TBL] [Abstract][Full Text] [Related]
32. Production and characterization of monoclonal antibodies directed against high and low molecular weight kininogens.
Hentges F; Kohnen M; Grigioni F; Reichert P; Humbel R; Schneider F
Bull Soc Sci Med Grand Duche Luxemb; 1994; 131(2):9-17. PubMed ID: 7820912
[TBL] [Abstract][Full Text] [Related]
33. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of nephrectomy and surgery on plasma kininogens and angiotensinogen in the rat.
Suzuki H; Alhenc-Gelas F; Bouhnik J; Corvol P; Ménard J
Endocrinology; 1988 Jun; 122(6):2809-15. PubMed ID: 3371263
[TBL] [Abstract][Full Text] [Related]
35. A rapid radioimmunoassay for rat plasma kininogen.
Bedi GS; Back N
Adv Exp Med Biol; 1986; 198 Pt B():495-501. PubMed ID: 3812108
[TBL] [Abstract][Full Text] [Related]
36. Single-step purification of "kallikrein-resistant" kininogen from rat plasma using monoclonal-antibody immunoaffinity chromatography.
Bedi GS; Back N
Prep Biochem; 1985; 15(3):159-69. PubMed ID: 3851460
[TBL] [Abstract][Full Text] [Related]
37. Human kininogens interact with M protein, a bacterial surface protein and virulence determinant.
Ben Nasr AB; Herwald H; Müller-Esterl W; Björck L
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):173-80. PubMed ID: 7826326
[TBL] [Abstract][Full Text] [Related]
38. Tissue-Specific expression of rat kininogen mRNAs.
Takano M; Sakanaka F; Yayama K; Okamoto H
Biol Pharm Bull; 2000 Oct; 23(10):1239-42. PubMed ID: 11041259
[TBL] [Abstract][Full Text] [Related]
39. Comparison of properties of monoclonal and polyclonal antibodies against the light chain of human high molecular weight kininogen.
Kleniewski J; Dingle S; Donaldson VH
J Lab Clin Med; 1988 Jan; 111(1):93-103. PubMed ID: 2447215
[TBL] [Abstract][Full Text] [Related]
40. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
